Clinical Trials Logo

1Q21 Amplification clinical trials

View clinical trials related to 1Q21 Amplification.

Filter by:
  • None
  • Page 1

NCT ID: NCT04008888 Recruiting - Multiple Myeloma Clinical Trials

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Start date: January 5, 2018
Phase: N/A
Study type: Interventional

The clinical trial was conducted in a cohort of young, high-risk myeloma patients who were designed to receive a combination of high-dose chemotherapy with allogeneic or autologous hematopoietic stem cell transplantation. The objective was to assess the progression free survival (PFS), overall survival (OS),and overall response rate (ORR) of the overall treatment.